Globus Medical, Inc.
GMED
$58.74
-$0.88-1.48%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 168.81% | 184.71% | -48.87% | 63.21% | 546.26% |
| Total Depreciation and Amortization | 6.86% | -3.06% | 1.91% | 4.93% | 15.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -632.72% | -70.46% | 76.63% | -33.89% | 61.58% |
| Change in Net Operating Assets | -689.81% | -64.79% | -21.78% | 129.80% | -173.79% |
| Cash from Operations | -56.08% | -15.71% | 3.28% | 275.34% | 3.57% |
| Capital Expenditure | -28.97% | -110.99% | 59.21% | -50.92% | 2.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | 97.95% | 61.37% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 292.49% | -421.25% | 21.42% | 515.61% |
| Cash from Investing | -327.66% | 226.18% | -595.68% | -44.22% | 77.72% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -58.15% | -83.80% | 194.76% | 65.09% | 317.17% |
| Repurchase of Common Stock | 86.69% | -20,536.40% | -11.19% | 59.67% | 97.65% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.16% | 54.85% | -179.56% | 10.56% | 88.69% |
| Cash from Financing | 96.08% | -1,163.73% | 205.02% | 124.86% | 107.53% |
| Foreign Exchange rate Adjustments | 305.76% | 182.73% | -205.06% | 7.92% | 213.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.27% | -299.89% | -23.86% | 276.75% | 149.78% |